AARGD-21-848397 |
2021 |
$150000 |
RACE-SPECIFIC REGIONAL TAU DEPOSITION AND ROLE OF OBSTRUCTIVE SLEEP APNEA |
Omonigho Bubu |
NEW YORK UNIVERSITY SCHOOL OF MEDICINE |
AARGD-21-850744 |
2021 |
$149871 |
Non-Invasive Assays of Sleep Microarchitecture and Thalamic Engagement |
Carmen Varela |
FLORIDA ATLANTIC UNIVERSITY |
AARGD-21-850411 |
2021 |
$150000 |
Allostatic states of stress and preclinical stages of cognitive dysfunction |
Dr. Juliana Nery De Souza Talarico |
The University of Iowa |
AARGD-21-847204 |
2021 |
$150000 |
Establishing the role of PERK activation on the progression of tauopathy. |
Jose Francisco Abisambra jabisamb |
UNIVERSITY OF FLORIDA |
AARGD-21-852114 |
2021 |
$149920 |
Protective effects of ApoE Christchurch on AD-related neurodegeneration |
Yakeel Quiroz |
Massachusetts General Hospital (Mass General) |
AARGD-21-850785 |
2021 |
$149999 |
Investigating apolipoprotein E receptor 2 in Alzheimer's disease |
Abdel Ali Belaidi |
Florey Institute of Neuroscience and Mental Health |
AARGD-21-850670 |
2021 |
$149850 |
Reactive astrocyte phenotypes in the pre-amyloid phase |
Dr. Eduardo Zimmer |
Federal University Of Rio Grande do Sul |
AARGD-21-850293 |
2021 |
$150000 |
Examining Health Literacy as a Risk factor for Dementia in Afro-Caribbeans |
Stephanie Chrisphonte |
Miller School of Medicine of the University of Miami |
AARGD-21-846545 |
2021 |
$97631 |
Subjective cognitive decline and cognitive reserve: a multimodal approach |
Raphael Machado Castilhos |
Fundação Médica do Rio Grande do Sul (Medical Foundation of Rio Grande do Sul) |
AARGD-21-850835 |
2021 |
$149843 |
Improving glymphatic and microvascular function in Alzheimer's disease |
Dr. Paulo Wagner Pires |
Arizona Board of Regents, University of Arizona |
AARGD-21-852381 |
2021 |
$119974 |
Development of a Valid Spatial Environment Assessment tooL (SEAL) for LTCFs |
Dr. FARHANA FERDOUS |
The Howard University Inc. |